Medication safety
The Department of Health oversees a range of strategies to reduce the risk of patient harm from medication-related incidents. These include providing support and expert medication safety advice to public and private health providers and developing and issuing patient safety notifications, fact sheets, practice guidelines, forms and charts.
Guidelines
- Aminoglycoside Dosing in Adults guideline (PDF 931 kB)
- Anticoagulant for hospitalised adult patients (PDF 2356 kB)
- Guideline for the Management of Adult Patients with Heparin-Induced Thrombocytopenia (HIT) (PDF 422 kB)
- Iron polymaltose slow intravenous infusion guideline (PDF 255 kB)
- Paracetamol - Guideline for safe paracetamol use (PDF 464 kB)
- Prescribing Electrolyte Disturbances in Adults (PDF 258 kB)
- Prescribing Intravenous Fluids for Adults (PDF 364 kB)
- Warfarin (PDF 393 kB)—Guidelines for management of Warfarin in the community
- Venous thromboembolism (VTE) Prevention
Resources
Fact Sheets
- Discontinuation of Protaphane® InnoLet® and other insulin products (PDF 148 kB) (19 December 2024)
- Constrained supply of morphine oral liquid (PDF 776 kB) (17 July 2024)
- Reports of belladonna toxicity from colic preparation (PDF 157 kB) (3 June 2024)
- 2024 Update to the Guideline for Warfarin Management in the Community (PDF 134 kB) (23 April 2024)
- Benzathine benzylpenicillin is not ‘BenPen’ (PDF 231 kB) (22 January 2024)
Contact
Medication Safety
Email: MedicationSafety@health.qld.gov.au